Swedencare Stock Tumbles After Q2 Earnings Miss, North American Slowdown

Shares of Swedencare (STO:SECARE) plummeted Wednesday after the company's second-quarter 2026 report revealed both revenue and profitability figures that failed to meet market expectations, triggering a significant sell-off.

Double Miss on Revenue and Profit

According to the half-year report released early Wednesday, Swedencare posted financial results that missed consensus estimates on both the top and bottom lines. While the company achieved some year-over-year growth, the figures were not strong enough to satisfy investor expectations.

Key financial metrics for the second quarter include:

• Net Sales: SEK 670 million, missing consensus by 4%.
• Operational EBITDA: SEK 129 million, falling 5% short of forecasts.
• Overall Revenue Growth: 4% year-over-year (7% organically).
• Operational EBITDA Margin: 19.3%, a slight increase from 19.0% in the prior-year period.

North American Growth Falters

Ad

A key point of concern for investors was a notable slowdown in the strategically important North American market. The company reported that organic growth in the region declined by 3%, a setback attributed to a delayed product launch delivery through its FDMC distribution channel.

This stumble in a critical growth market overshadowed the modest overall revenue growth and margin improvement, signaling potential challenges to the company's expansion strategy.

Market Reaction and Outlook

The market's reaction to the disappointing report was immediate, with Swedencare shares falling 15.7% to trade at SEK 21.8. During the session, the stock hit a new 52-week low of SEK 21.35, a steep drop from its 52-week high of SEK 44.3.

The earnings miss puts pressure on the stock and may prompt analysts to revise their price targets and ratings in the coming days. The sell-off was exacerbated by a generally weaker market backdrop, with major indexes in both Sweden and the U.S. trading in negative territory.